Summit Trail Advisors, LLC Amgen Inc Transaction History

Summit Trail Advisors, LLC

$3.71 Billion
Q1 2024

A detailed history of Summit Trail Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, Summit Trail Advisors, LLC holds 5,158 shares of AMGN stock, worth $1.61 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

5,158

Previous 4,733 8.98%

Holding current value

$1.61 Million

Previous $1.36 Million 7.56%

% of portfolio

0.04%

Previous 0.05%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 23, 2024	BUY	$268.87 - $324.56 $114,269 - $137,938	425 Added 8.98%	5,158 $1.47 Million
Q4 2023 Feb 06, 2024	SELL	$255.7 - $288.46 $59,578 - $67,211	-233 Reduced 4.69%	4,733 $1.36 Million
Q3 2023 Oct 30, 2023	BUY	$218.65 - $271.46 $146,495 - $181,878	670 Added 15.6%	4,966 $1.33 Million
Q2 2023 Jul 25, 2023	BUY	$214.27 - $253.37 $415,898 - $491,791	1,941 Added 82.42%	4,296 $953,000
Q1 2023 May 04, 2023	SELL	$225.79 - $275.2 $63,898 - $77,881	-283 Reduced 10.73%	2,355 $569,000

Q4 2022 Feb 07, 2023	BUY	$229.03 - $291.01 $58,402 - $74,207	255 Added 10.7%	2,638 $692,000
Q3 2022 Nov 09, 2022	BUY	$224.46 - $253.15 $128,840 - $145,308	574 Added 31.73%	2,383 $537,000
Q2 2022 Aug 09, 2022	BUY	$230.71 - $256.74 $135,426 - $150,706	587 Added 48.04%	1,809 $440,000
Q1 2022 May 16, 2022	SELL	$219.27 - $242.57 $4,604 - $5,093	-21 Reduced 1.69%	1,222 $295,000
Q4 2021 Feb 11, 2022	SELL	$198.88 - $227.6 $94,865 - $108,565	-477 Reduced 27.73%	1,243 $280,000
Q3 2021 Nov 16, 2021	BUY	$212.27 - $248.7 $69,200 - $81,076	326 Added 23.39%	1,720 $366,000
Q2 2021 Aug 16, 2021	BUY	$233.58 - $259.14 $325,610 - $361,241	1,394 New	1,394 $340,000
Q1 2021 May 17, 2021	SELL	$221.91 - $258.6 $252,755 - $294,545	-1,139 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$216.38 - $257.67 $123,769 - $147,387	-572 Reduced 33.43%	1,139 $262,000
Q3 2020 Nov 16, 2020	BUY	$234.65 - $260.95 $401,486 - $446,485	1,711 New	1,711 $406,000
Q3 2020 Nov 16, 2020	SELL	$234.65 - $260.95 $270,786 - $301,136	-1,154 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$197.81 - $242.74 $228,272 - $280,121	1,154 New	1,154 $272,000
Q4 2018 Feb 13, 2019	SELL	$178.4 - $208.25 $247,976 - $289,467	-1,390 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$185.29 - $208.89 $257,553 - $290,357	1,390 New	1,390 $288,000
Q2 2018 Aug 10, 2018	SELL	$166.05 - $186.51 $472,080 - $530,247	-2,843 Closed	0 $0
Q1 2018 May 22, 2018	SELL	$169.43 - $198.0 $73 Million - $85.3 Million	-430,667 Reduced 99.34%	2,843 $434,000
Q1 2018 May 21, 2018	BUY	$169.43 - $198.0 $73 Million - $85.3 Million	430,892 Added 16458.82%	433,510 $434,000
Q4 2017 Feb 14, 2018	BUY	$168.79 - $188.59 $441,892 - $493,728	2,618	2,618 $492,000

Others Institutions Holding AMGN

# of Institutions

2,930

Shares Held

401M

Call Options Held

6.59M

Put Options Held

6.6M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $167B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Summit Trail Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Summit Trail Advisors, LLC with notifications on news.

Account

Summit Trail Advisors, LLC Amgen Inc Transaction History